A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines - PubMed (original) (raw)
Comparative Study
A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines
Anna M Sawka et al. J Clin Endocrinol Metab. 2003 Feb.
Abstract
We compared the diagnostic efficacy of fractionated plasma metanephrine measurements to measurements of 24-h urinary total metanephrines and catecholamines in outpatients tested for pheochromocytoma at Mayo Clinic Rochester from January 1, 1999, until November 27, 2000. Catecholaminesecreting tumors were histologically proven. The sensitivity of fractionated plasma metanephrines was 97% (30 of 31 patients), compared with a sensitivity of 90% (28 of 31) for urinary total metanephrines and catecholamines (P = 0.63). The specificity of fractionated plasma metanephrines was 85% (221 of 261), compared with 98% (257 of 261; P < 0.001) for urinary measurements. The likelihood ratios for positive tests were 6.3 (95% confidence interval, 4.7 to 8.5) for fractionated plasma metanephrines and 58.9 (95% confidence interval, 22.1 to 156.9) for urinary total metanephrines and catecholamines. An adrenal pheochromocytoma was missed by urinary testing in two patients with familial syndromes and one asymptomatic patient with an incidentally discovered adrenal mass. An extra-adrenal paraganglioma was missed by plasma testing in one patient. In conclusion, measurements of 24-h urinary total metanephrines and catecholamines yield fewer false-positive results, an attribute preferred for testing low-risk patients, but fractionated plasma metanephrine measurements may be preferred in high-risk patients with familial endocrine syndromes.
Comment in
- Editorial: biochemical diagnosis of pheochromocytoma--is it time to switch to plasma-free metanephrines?
Eisenhofer G. Eisenhofer G. J Clin Endocrinol Metab. 2003 Feb;88(2):550-2. doi: 10.1210/jc.2002-021913. J Clin Endocrinol Metab. 2003. PMID: 12574178 Review. No abstract available. - Persistent neutrophilia as a preceding symptom of pheochromocytoma.
Sevastos N, Theodossiades G, Malaktari S, Archimandritis AJ. Sevastos N, et al. J Clin Endocrinol Metab. 2005 Apr;90(4):2472; author reply 2472-3. doi: 10.1210/jc.2005-0180. J Clin Endocrinol Metab. 2005. PMID: 15814778 No abstract available.
Similar articles
- Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT, Frystyk J, Poulsen PL. Christensen TT, et al. Scand J Clin Lab Invest. 2011 Dec;71(8):695-700. doi: 10.3109/00365513.2011.622410. Epub 2011 Oct 24. Scand J Clin Lab Invest. 2011. PMID: 22023043 - The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young WF Jr. Perry CG, et al. Clin Endocrinol (Oxf). 2007 May;66(5):703-8. doi: 10.1111/j.1365-2265.2007.02805.x. Epub 2007 Mar 27. Clin Endocrinol (Oxf). 2007. PMID: 17388796 - Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic Acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma.
Boyle JG, Davidson DF, Perry CG, Connell JM. Boyle JG, et al. J Clin Endocrinol Metab. 2007 Dec;92(12):4602-8. doi: 10.1210/jc.2005-2668. Epub 2007 Jul 17. J Clin Endocrinol Metab. 2007. PMID: 17635948 - New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines.
Lenders JW, Pacak K, Eisenhofer G. Lenders JW, et al. Ann N Y Acad Sci. 2002 Sep;970:29-40. doi: 10.1111/j.1749-6632.2002.tb04410.x. Ann N Y Acad Sci. 2002. PMID: 12381539 Review. - Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.
Därr R, Kuhn M, Bode C, Bornstein SR, Pacak K, Lenders JWM, Eisenhofer G. Därr R, et al. Endocrine. 2017 Jun;56(3):495-503. doi: 10.1007/s12020-017-1300-y. Epub 2017 Apr 12. Endocrine. 2017. PMID: 28405881 Free PMC article. Review.
Cited by
- Is It Enough to Diagnose Pheochromocytoma by Measuring Urine Metanephrines Levels?
Houssein M, Aydın C, Köroğlu EY, Tam AA, Sezer S, Devran Z, Topaloglu O, Ersoy R, Cakir B. Houssein M, et al. Cureus. 2024 Sep 16;16(9):e69560. doi: 10.7759/cureus.69560. eCollection 2024 Sep. Cureus. 2024. PMID: 39421117 Free PMC article. - Screening and treatment of endocrine hypertension focusing on adrenal gland disorders: a narrative review.
Chung SM. Chung SM. J Yeungnam Med Sci. 2024 Oct;41(4):269-278. doi: 10.12701/jyms.2024.00752. Epub 2024 Sep 19. J Yeungnam Med Sci. 2024. PMID: 39295528 Free PMC article. - Dilute, derivatise and shoot: Measurement of urinary free metanephrines and catecholamines as ethyl derivatives by LC-MSMS.
Ellis AG, Zeglinski PT, Coleman KE, Whiting MJ. Ellis AG, et al. Clin Mass Spectrom. 2017 Sep 5;4-5:34-41. doi: 10.1016/j.clinms.2017.08.005. eCollection 2017 Apr-Aug. Clin Mass Spectrom. 2017. PMID: 39193131 Free PMC article. - Micturition Hypertension in an Adolescent.
Jakamy R, Ugoani EO, El Khorassani M, Ibat D, Oulahyane R. Jakamy R, et al. JACC Case Rep. 2024 Aug 7;29(15):102435. doi: 10.1016/j.jaccas.2024.102435. eCollection 2024 Aug 7. JACC Case Rep. 2024. PMID: 39157546 Free PMC article. - An Unusual Case of Pheochromocytoma Associated with von Hippel-Lindau Disease and Lynch Syndrome During Pregnancy.
Tang M, Meng S. Tang M, et al. JCEM Case Rep. 2024 Jun 21;2(6):luae097. doi: 10.1210/jcemcr/luae097. eCollection 2024 Jun. JCEM Case Rep. 2024. PMID: 38911362 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical